|
![]() |
Diabetes > HLA (Human Leukocyte Antigen)
The following information is about HLA (Human Leukocyte Antigen).
HLA (Human Leukocyte Antigen) Defined
A pattern of cell surface proteins that identifies the cell to the immune system as 'self' or 'non-self'. Certain patterns (haplotypes) as defined by DNA analysis can indicate a susceptibility to Type 1 diabetes.
This definition is in context to Diabetes. See more contextual defintions for HLA (Human Leukocyte Antigen).
Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate For Rheumatoid Arthritis
Published August 21, 2008, 3:15 am, Medical News Today
Pipex Pharmaceuticals, Inc.
QIAGEN Unveils Diagnostic Assay In The EU To Detect Genetic Variation Causing Adverse Reactions In AIDS Patients
Published August 19, 2008, 7:13 am, Medical News Today
QIAGEN (Nasdaq: QGEN; Frankfurt Prime Standard: QIA) announced that it has introduced a new molecular diagnostic test to type the HLA-B*5701 allele, a genetic variation in the Human Leucocyte Antigen (HLA) system.
Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid Arthritis
Published August 19, 2008, 5:54 am, Marketwire via Yahoo! Finance
Pipex Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, today announced that it has acquired an oral, once-daily candidate for the treatment of rheumatoid arthritis which has completed a 160 patient, multi-center, double-blind, randomized, placebo-controlled Phase II ...
19.08.2008 - DJ HUGIN NEWS/QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse ...
Published August 19, 2008, 1:02 am, 4investors
Venlo, The Netherlands - August 19, 2008 - QIAGEN (Nasdaq: QGEN; Frankfurt Prime Standard: QIA) today announced that it has introduced a new molecular diagnostic test to type the HLA-B*5701 allele, a genetic variation in the Human Leucocyte Antigen (HLA) system.
DJ HUGIN NEWS/QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS ...
Published August 19, 2008, 12:42 am, Financial.de
HLA-B*5701 biomarker indicates risk for severe adverse reactions to Abacavir / Experts expect more tests for similar markers in the future Venlo, The Netherlands - August 19, 2008 - QIAGEN (Nasdaq: QGEN; Frankfurt Prime Standard: QIA) today announced that it has introduced a new molecular diagnostic test to type the HLA-B*5701 allele, a genetic variation in the Human Leucocyte Antigen (HLA) ...
QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS Patients
Published August 18, 2008, 11:45 pm, Marketwire via Yahoo! Finance
HLA-B*5701 biomarker indicates risk for severe adverse reactions to Abacavir / Experts expect more tests for similar markers in the future
Searching for similarities
Published August 15, 2008, 11:06 am, The Russellville Courier
More than 60 tested as potential bone marrow donors By Holly Ruppel Reporter Because of the charity and goodwill of her friends and neighbors, Rachelle “Rockie” Richardson, who has fought off cancer for almost 10 years, may find a matching donor for the bone marrow transplant she desperately needs.
Noble Financial Capital Markets M.A.D. MAX Equity Conference Presenter Profiles
Published August 15, 2008, 9:11 am, Broadcast Newsroom
LAKE LAS VEGAS , Nev., BUSINESS WIRE -- The Noble Financial Capital Markets M.A.D. MAX Equity Conference takes place August 18, 2008 - August 19, 2008 at Loews Lake Las Vegas in Henderson.
Noble Financial Capital Markets M.A.D. MAX Equity Conference Presenter Profiles
Published August 15, 2008, 8:30 am, Centre Daily Times
The Noble Financial Capital Markets M.A.D. MAX Equity Conference takes place August 18, 2008 - August 19, 2008 at Loews Lake Las Vegas in Henderson. Listed below are the Noble Financial Capital Markets M.A.D. MAX Equity Conference presenter profiles. For in-depth information about the event, visit http://www.noblemadmax.com/madmaxhome.htm.
Noble Financial Capital Markets M.A.D. MAX Equity Conference Presenter Profiles
Published August 15, 2008, 8:04 am, Business Wire via Yahoo! Finance
LAKE LAS VEGAS, Nev.----The Noble Financial Capital Markets M.A.D. MAX Equity Conference takes place August 18, 2008 - August 19, 2008 at Loews Lake Las Vegas in Henderson. Listed below are the Noble Financial Capital Markets M.A.D.
Are you looking for additional Diabetes > Hla (human Leukocyte Antigen) news? Try our new "Hla (human Leukocyte Antigen) News Focus" area.
Social bookmarks are not available at the moment.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > HLA (Human Leukocyte Antigen). If you would like to find related tags we recommend Tag Patterns > HLA (Human Leukocyte Antigen)
Off-site Hla (human Leukocyte Antigen) Research Links
If you still need additional information on Hla (human Leukocyte Antigen) then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > HLA (Human Leukocyte Antigen)
- Alexa > HLA (Human Leukocyte Antigen)
- Anti-Aging Revolution > HLA (Human Leukocyte Antigen)
- DMOZ > HLA (Human Leukocyte Antigen)
- Feeds Filtered > HLA (Human Leukocyte Antigen)
- Google > HLA (Human Leukocyte Antigen)
- News Meme > HLA (Human Leukocyte Antigen)
- Nuah: News > HLA (Human Leukocyte Antigen)
- The Feed Directory > HLA (Human Leukocyte Antigen)
- OBP > HLA (Human Leukocyte Antigen)
- Open Tag Directory > HLA (Human Leukocyte Antigen)
- Podzy > HLA (Human Leukocyte Antigen)
- Yahoo > HLA (Human Leukocyte Antigen)
Diabetes Topics
Everything you need to know about Diabetes
Diabetes
If you know the Diabetes Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Diabetes.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.
